title: Understanding the role of MET kinase in cancer therapy.
authors.forename: Edwin M
authors.initials: EM
authors.lastname: Posadas
authors.forename: Robert A
authors.initials: RA
authors.lastname: Figlin
mesh_terms: D000813:Anilides / Q000008:administration & dosage*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage*; D019859:Proto-Oncogene Proteins c-met / Q000037:antagonists & inhibitors*; D011804:Quinolines / Q000008:administration & dosage*; D040301:Vascular Endothelial Growth Factor Receptor-2 / Q000037:antagonists & inhibitors*
chemical_list: D000813:Anilides; C544831:GSK 1363089; D047428:Protein Kinase Inhibitors; D011804:Quinolines; C491743:MET protein, human; D019859:Proto-Oncogene Proteins c-met; D040301:Vascular Endothelial Growth Factor Receptor-2